This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASCO GU 2025
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
ASCO GU 2024
ASCO GU 2024 Prostate Cancer
ASCO GU 2024
Prostate Cancer
Bladder Cancer
Kidney Cancer
Penile, Urethral, Testicular, and Adrenal Cancers
Upper Tract Urothelial Carcinoma
Press Releases
ASCO GU 2024 Prostate Cancer
Viewing 10601-10620 of 11879 articles
#WCE2014 - Oncological outcomes after radical prostatectomy for high-risk prostate cancer - Interview
#WCE2014 - Laparoscopic adrenalectomy: 15-years experiences of a single surgeon in Korea - Interview
#WCE2014 - Renal surgery in the elderly: Validation of perioperative outcomes and postoperative complications in 160 consecutive patients undergoing retroperitoneoscopic partial nephrectomy - Interview
#WCE2014 - Patients undergoing ureteroscopic lithotripsy may be excellent single session SWL candidates based upon triple D score - Interview
#WCE2014 - Evaluation of kidney function post-irreversible electroporation in comparison to partial nephrectomy and radiofrequency ablation in a porcine solitary kidney model - Interview
#WCE2014 - How a donor nephrectomy population can help clarify warm renal ischemia effects during partial nephrectomy - Interview
#WCE2014 - Acute bleeding requiring re-operation in minimally invasive urologic surgery - Interview
#WCE2014 - Co-targeting of NFkB and survivin by YM155 results in profound in vitro growth inhibition of renal cell carcinoma (RCC) - Interview
#WCE2014 - Ultra low dose CT-KUB to detect kidney stones with 50% less radiation: Is the plain radiograph obsolete? - Session Highlights
#WCE2014 - Open, laparoscopic, and robot-assisted renal surgery practice patterns: The impact of technology on adoption curves for minimally invasive partial nephrectomy - Session Highlights
AUGS/IUGA 2014 - Poster: Close encounters – the sacral needle depth at the sacral promontory: A randomized comparison of surgeon training and surgical approach
AUGS/IUGA 2014 - Poster: Disc at risk: Investigation of sacral suture depth in minimally invasive sacrocolpopexy
AUGS/IUGA 2014 - Poster: Underestimation of microscopic hematuria in a urogynecologic population
AUGS/IUGA 2014 - Poster: Health resource utilization and burden in overactive bladder patients treated with anticholinergics
AUGS/IUGA 2014 - Poster: Burden on secondary care of overactive bladder patients who are inadequately managed with anticholinergics in England
#AUA14 - Multiparametric prostate MRI and MRI/ultrasound fusion biopsy in the follow-up of prostate cancer progression for men on active surveillance - Slide Presentation
#ASCO14 - Poster: Preliminary product parameter and safety results from NeuACT, a phase 2 randomized, open-label trial of DN24-02 in patients with surgically resected HER2+ urothelial cancer at high risk for recurrence
#ASCO14 - Poster: Activity of abiraterone acetate in metastatic castration-resistant prostate cancer patients previously treated with ketoconazole: A prospective phase II study from the Prostate Cancer Clinical Trials Consortium
#ASCO14 - The site of visceral metastases to predict overall survival in castration-resistant prostate cancer (CRPC) patients: A meta-analysis of five phase III trials - Session Highlights
#ASCO14 - Final results of EORTC intergroup randomized phase III trial comparing immediate vs deferred chemotherapy after radical cystectomy in patients with pT3T4 and/or N+ M0 transitional cell carcinoma (TCC) of the bladder - Session Highlights
526
527
528
529
530
531
532
533
534
535
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free